Metraipolis › archive › dc_dcb170fa6a8e
A low-dose immunotherapy targeting Fc gamma Receptors and heparan sulfate proteoglycan to impact myeloid cells and control cancers with diverse… — Europe PMC PMID:42564443
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42564443
- DOI
- 10.3389/fimmu.2026.1734778
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-17T21:28:07.398Z
- SHA-256 of the archived text
104151faa7739462f0d0a60c861e8c8d147f9317d9716a0385c165d94ddbf310- Stable URL of this page
https://metraipolis.com/documento/dc_dcb170fa6a8e
How to cite
A low-dose immunotherapy targeting Fc gamma Receptors and heparan sulfate proteoglycan to impact myeloid cells and control cancers with diverse… — Europe PMC PMID:42564443 — Europe PMC (en), https://europepmc.org/article/MED/42564443 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dcb170fa6a8e (Metraipolis archive dc_dcb170fa6a8e, sha256 104151faa7739462f0d0a60c861e8c8d147f9317d9716a0385c165d94ddbf310)
BibTeX
@misc{dcdcb170fa6a8e,
title = {A low-dose immunotherapy targeting Fc gamma Receptors and heparan sulfate proteoglycan to impact myeloid cells and control cancers with diverse… — Europe PMC PMID:42564443},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42564443},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dcb170fa6a8e; sha256 104151faa7739462f0d0a60c861e8c8d147f9317d9716a0385c165d94ddbf310},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42564443. Agents can read the archived copy with the MCP tool read_document.